| Dr Lewis David Slawsky, MD | |
|
615 Smithview Dr, Maryville, TN 37803-6100 | |
| (865) 380-9300 | |
| (865) 380-1558 |
| Full Name | Dr Lewis David Slawsky |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 37 Years |
| Location | 615 Smithview Dr, Maryville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497767529 | NPI | - | NPPES |
| 3144148 | Other | TN | BCBS PROVIDER NUMBER |
| 3091975 | Medicaid | TN | |
| 4619423 | Other | TN | AETNA PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD0000026250 (Tennessee) | Primary |
| Entity Name | Advanced Dermatology Of East Tennessee, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033121157 PECOS PAC ID: 9032377403 Enrollment ID: O20120215000414 |
News Archive
A new study in the Oxford Economic Papers finds that migration flows the last 500 years from high sunlight regions to low sunlight regions influence contemporary health outcomes in destination countries.
The Republican-led Congress was unable to repeal the Affordable Care Act in 2017, but the Trump administration continues to implement elements of the failed GOP bill using executive authority. The latest change would make it easier for states to waive some major parts of the health law, including allowing subsidies for people to buy insurance plans that don't meet all the law's requirements.
Eisai Inc. announced today that the Phase III ACCESS (A Controlled Comparison of Eritoran and Placebo in Patients with Severe Sepsis) trial of the investigational compound eritoran (E5564) will continue enrolling to the preset goal of 2,000 patients. As part of a planned interim analysis, an independent Data Monitoring Committee (DMC) has evaluated efficacy and safety data on the first 1,500 subjects to complete the 28-day follow-up in the Phase III ACCESS trial.
A BLOOD test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study published in the journal Cancer Discovery today (Monday).
Congress can't seem to stop its debate on birth control - and one reason is that it's bringing in lots of votes and money. ... Republicans are also using the issue to raise money among conservatives and broaden GOP support among Catholics, who are strongly opposed to Obama's contraceptive mandate. But, in general, the flap over birth control is helping Democrats solidify their base and gives them an opening to appeal to independent women, said Jennifer Duffy of the Cook Political Report.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lewis David Slawsky, MD 615 Smithview Dr, Maryville, TN 37803-6100 Ph: (865) 380-9300 | Dr Lewis David Slawsky, MD 615 Smithview Dr, Maryville, TN 37803-6100 Ph: (865) 380-9300 |
News Archive
A new study in the Oxford Economic Papers finds that migration flows the last 500 years from high sunlight regions to low sunlight regions influence contemporary health outcomes in destination countries.
The Republican-led Congress was unable to repeal the Affordable Care Act in 2017, but the Trump administration continues to implement elements of the failed GOP bill using executive authority. The latest change would make it easier for states to waive some major parts of the health law, including allowing subsidies for people to buy insurance plans that don't meet all the law's requirements.
Eisai Inc. announced today that the Phase III ACCESS (A Controlled Comparison of Eritoran and Placebo in Patients with Severe Sepsis) trial of the investigational compound eritoran (E5564) will continue enrolling to the preset goal of 2,000 patients. As part of a planned interim analysis, an independent Data Monitoring Committee (DMC) has evaluated efficacy and safety data on the first 1,500 subjects to complete the 28-day follow-up in the Phase III ACCESS trial.
A BLOOD test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing, according to a study published in the journal Cancer Discovery today (Monday).
Congress can't seem to stop its debate on birth control - and one reason is that it's bringing in lots of votes and money. ... Republicans are also using the issue to raise money among conservatives and broaden GOP support among Catholics, who are strongly opposed to Obama's contraceptive mandate. But, in general, the flap over birth control is helping Democrats solidify their base and gives them an opening to appeal to independent women, said Jennifer Duffy of the Cook Political Report.
› Verified 8 days ago
Dr. Patrick Henry Burkhart, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1702 E Lamar Alex Pkwy, Maryville, TN 37804 Phone: 865-977-0555 Fax: 865-681-0963 |